University Alzheimer’s drug human trials boost

Lancaster University scientists are celebrating a major breakthrough with a revolutionary new drug that could prevent the early stages of Alzheimer’s for thousands of people worldwide.

The news, announced during Dementia Awareness Week From May 17-23, means that the drug will now be tested on humans.

It is encouraging that our drug is being taken forward and will be tested on humans

Lancaster University has filed a patent application and the drug will be progressing into clinical trials run by the North West research company MAC Clinical Research.